Literature DB >> 19504098

Matrix metalloproteinase gene polymorphisms in patients with rheumatoid arthritis.

Sabrina Scherer1, Thais Barboza de Souza, Juliana de Paoli, Claiton Viegas Brenol, Ricardo Machado Xavier, João Carlos Tavares Brenol, José Artur Chies, Daniel Simon.   

Abstract

Several genetic factors seem to be involved in the pathogenesis of rheumatoid arthritis (RA). The aim of this study was to analyze whether functional polymorphisms in the promoter region of the MMP-1, -3 and -9 genes were associated with RA. The study population comprises 110 RA patients and 100 healthy controls. The -1607 1G/2G MMP-1, -1171 5A/6A MMP-3, and -1562 C/T MMP-9 polymorphisms were analyzed. The frequency of the 5A allele of MMP-3 gene was significantly higher in the controls when compared with the RA patients (0.45 vs. 0.32, P < 0.01). No significant differences were observed in the allele frequencies for the MMP-1 and -9 polymorphisms between RA patients and controls. Individuals carrying MMP-3 5A allele have significant higher frequency of extra-articular manifestations and rheumatoid nodules than individuals homozygous for 6A allele (P < 0.05). The results presented in this study provide evidence of an association between the MMP-3 gene polymorphism and RA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19504098     DOI: 10.1007/s00296-009-0974-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  22 in total

Review 1.  Matrix metalloproteinases.

Authors:  H Nagase; J F Woessner
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

Review 2.  Matrix metalloproteinases as modulators of inflammation and innate immunity.

Authors:  William C Parks; Carole L Wilson; Yolanda S López-Boado
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

Review 3.  Investigating the genetic basis of susceptibility to rheumatoid arthritis.

Authors:  Jane Worthington
Journal:  J Autoimmun       Date:  2005-10-27       Impact factor: 7.094

4.  Collagenase-1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal study.

Authors:  Arnaud Constantin; Valérie Lauwers-Cancès; Frédérique Navaux; Michel Abbal; Joost van Meerwijk; Bernard Mazières; Anne Cambon-Thomsen; Alain Cantagrel
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

Review 5.  Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases.

Authors:  S Ye
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

Review 6.  Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?

Authors:  S Gay; R E Gay; W J Koopman
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

Review 7.  Matrix metalloproteinase-9 and autoimmune diseases.

Authors:  Maya Ram; Yaniv Sherer; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2006-05-02       Impact factor: 8.317

8.  Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: Association with severity and progression of rheumatoid arthritis in a prospective study.

Authors:  Arnaud Constantin; Valérie Lauwers-Cancès; Frédérique Navaux; Michel Abbal; Joost van Meerwijk; Bernard Mazières; Anne Cambon-Thomsen; Alain Cantagrel
Journal:  Arthritis Rheum       Date:  2002-07

9.  Effect of matrix metalloproteinase-3 functional SNP on serum matrix metalloproteinase-3 level and outcome measures in Japanese RA patients.

Authors:  S Tsukahara; M Shinozaki; K Ikari; T Mochizuki; E Inoue; T Tomatsu; M Hara; H Yamanaka; N Kamatani; S Momohara
Journal:  Rheumatology (Oxford)       Date:  2008-01       Impact factor: 7.580

10.  Association of the 5A/6A promoter polymorphism of the MMP-3 gene with the radiographic progression of rheumatoid arthritis.

Authors:  Petr Nemec; Monika Pavkova-Goldbergova; Jindra Gatterova; Anna Vasku; Miroslav Soucek
Journal:  Ann N Y Acad Sci       Date:  2007-09       Impact factor: 5.691

View more
  6 in total

Review 1.  Polymorphisms of MMP-1 and MMP-3 and susceptibility to rheumatoid arthritis. A meta-analysis.

Authors:  C Zhang; L Chen; Y Gu
Journal:  Z Rheumatol       Date:  2015-04       Impact factor: 1.372

2.  Influence of MMP-8 promoter polymorphism in early osseointegrated implant failure.

Authors:  F R Costa-Junior; C C Alvim-Pereira; F Alvim-Pereira; P C Trevilatto; A P de Souza; Maria Cristina L G Santos
Journal:  Clin Oral Investig       Date:  2012-03-02       Impact factor: 3.573

3.  Tripterygium glycosides inhibit inflammatory mediators in the rat synovial RSC-364 cell line stimulated with interleukin-1β.

Authors:  Anji Cai; Suwen Qi; Zhuowa Su; Huaqing Shen; Wengsong Ma; Yong Dai
Journal:  Biomed Rep       Date:  2015-08-04

4.  Association of tumor necrosis factor-α (G-308A) genetic variant with matrix metalloproteinase-9 activity and joint destruction in early rheumatoid arthritis.

Authors:  Sonja Stojanovic; Tatjana Jevtovic Stoimenov; Jovan Nedovic; Valentina Zivkovic; Milena Despotovic; Dusica Pavlovic
Journal:  Clin Rheumatol       Date:  2017-06-01       Impact factor: 2.980

5.  Association of the polymorphisms of the genes APOC3 (rs2854116), ESR2 (rs3020450), HFE (rs1799945), MMP1 (rs1799750) and PPARG (rs1801282) with lipodystrophy in people living with HIV on antiretroviral therapy: a systematic review.

Authors:  Andreia Soares da Silva; Tatiana Lins Carvalho; Kleyton Palmeira do Ó; Débora Nascimento da Nóbrega; Roberta Dos Santos Souza; Victor Fernando da Silva Lima; Isabela Cristina Cordeiro Farias; Taciana Furtado de Mendonça Belmont; Maria do Socorro de Mendonça Cavalcanti; Demócrito de Barros Miranda-Filho
Journal:  Mol Biol Rep       Date:  2020-04-22       Impact factor: 2.316

6.  Lack of association of matrix metalloproteinase-3 gene polymorphism with susceptibility to rheumatoid arthritis: a meta-analysis.

Authors:  Zhitao Feng; Guochao He; Zhuanghong Chen; Zhengzhi Wu; Juan Li
Journal:  BMC Musculoskelet Disord       Date:  2014-11-18       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.